Peripheral Neuropathy Trial, Recruiting NCT05817786 Sponsor: Centre Hospitalier Universitaire de Nice Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT05817786
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old
  • You have chronic pain that has lasted more than 12 months, is moderate to severe, and has been identified by a specialist as nerve-related (neuropathic) pain
  • Your pain affects one arm or hand only (upper limb), and not both sides
  • Your pain comes from a nerve problem in the body (not the brain or spinal cord), which may include conditions such as complex regional pain syndrome (type I or II), or pain following an injury or surgery
  • Your pain has not improved despite trying multiple standard treatments, including certain antidepressants, nerve pain medications, skin patches or creams, talking therapies, and combinations of these
  • You have been assessed and approved by a specialist in chronic and nerve pain
  • You have signed a consent form agreeing to take part
  • You are covered by the French social insurance system

Who may not be able to join:

  • Your nerve pain is caused by a torn brachial plexus (a specific type of nerve injury in the shoulder/neck area)
  • Your nerve pain is caused by shingles (post-zoster pain)
  • You experience phantom limb pain (pain felt in a limb that has been amputated)
  • You are unable to fill in written questionnaires on your own
  • You have a long-term condition that requires you to have regular MRI scans
  • You have a health condition that makes surgery, general anaesthetic, or a specific procedure near the shoulder unsafe for you
  • You have a pacemaker, defibrillator, or a known heart condition that puts you at high risk (confirm with trial site)
  • You have unstable mental health or psychiatric conditions
  • You are pregnant or breastfeeding, under 18, under legal guardianship, or currently detained (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Denys FONTAINE, Centre Hospitalier Universitaire de Nice

Phone: 0492034702

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 February 2024
Est. completion
9 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

efficacity; efficacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov